Cordonnier Michael 4
4 · CARLSMED, INC. · Filed Jul 24, 2025
Insider Transaction Report
Form 4
CARLSMED, INC.CARL
Cordonnier Michael
DirectorCEO, President
Transactions
- Exercise/Conversion
Common Stock
2025-07-24+3,612→ 1,239,330 total - Conversion
Series B Preferred Stock
2025-07-24−3,612→ 0 total→ Common Stock (3,612 underlying) - Award
Stock Options (Right to Buy)
2025-07-22+142,857→ 726,235 totalExercise: $15.00Exp: 2035-07-09→ Common Stock (142,857 underlying)
Footnotes (2)
- [F1]These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date.
- [F2]The unvested stock options are convertible into approximately 142,857 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date.